A cluster-randomized trial to assess the efficacy of targeting trachoma treatment to children
Author(s) -
Abdou Amza,
Boubacar Kadri,
Beido Nassirou,
Sun Y. Cotter,
Nicole E. Stoller,
Zhaoxia Zhou,
Robin L. Bailey,
David Mabey,
Travis C. Porco,
Jeremy D. Keenan,
Bruce D. Gaynor,
Sheila K. West,
Thomas M. Lietman
Publication year - 2016
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciw810
Subject(s) - medicine , trachoma , azithromycin , confidence interval , randomized controlled trial , chlamydia , pediatrics , antibiotics , immunology , pathology , microbiology and biotechnology , biology
The World Health Organization recommends annual treatment of entire trachoma-endemic communities, although children typically have a higher load, longer duration, and greater likelihood of infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom